In this issue of Rheumatic Disease Clinics, guest editor Dr. Erin Janssen brings her considerable expertise to the topic of New and Emerging Rheumatic Diseases. Top experts in the field cover issues such as approach to diagnosing in-born errors of immunity; Type I interferonopathies; SOCS1 and immune dysregulation; manifestations of DADA2; COPA syndrome; and more.
Approach to Diagnosing Inborn Errors of Immunity Type I Interferonopathies: A Clinical Review Suppressor of Cytokine Signaling 1 Haploinsufficiency: A New Driver of Autoimmunity and Immunodysregulation Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment COPA Syndrome from Diagnosis to Treatment: A Clinicians Guide NF-kB and Related Autoimmune and Autoinflammatory Diseases Expanding IPEX: Inborn Errors of Regulatory T Cells Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders Genetic Defects in Early-Onset Inflammatory Bowel Disease Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis Targeted Treatment of Diseases of Immune Dysregulation
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.